[NRIX] YoY Quarter Result on 30-Nov-2020 [#Q4]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
16-Feb-2021
Financial Year
2020
Quarter
30-Nov-2020 [#Q4]
Profit Trend
QoQ- -7.54%
YoY- -47.30%
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Quarter Result
30/11/23 30/11/22 30/11/21 30/11/20 30/11/19 CAGR
Revenue 15,159 6,783 7,396 6,689 1,862 68.85%
PBT -41,956 -46,717 -37,658 -19,873 -13,309 33.22%
Tax 7,887 -5,010 44 41 210 147.40%
NP -41,956 -41,707 -37,702 -19,914 -13,519 32.70%
Tax Rate - - - - - -
Total Cost 57,115 48,490 45,098 26,603 15,381 38.78%
Ratio Analysis
30/11/23 30/11/22 30/11/21 30/11/20 30/11/19 CAGR
NP Margin -276.77 -614.88 -509.76 -297.71 -726.05 -21.41%
Per Share
30/11/23 30/11/22 30/11/21 30/11/20 30/11/19 CAGR
EPS -0.77 -0.77 -0.85 -0.51 -0.65 4.32%
EPS Diluted -0.77 -0.77 -0.85 -0.51 -0.65 4.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.